Treatment product

Abstract

Treatment means for aftercare following lip augmentation, wherein the treatment means are designed for application to the lips of persons, characterized in that the treatment means are a set (1) designed to carry out a multi-phase treatment with at least two treatment phases, wherein an acute treatment means is provided which is designed for lip treatment during an acute phase immediately following lip augmentation, comprising: - Arnica extract - Menthol - Lecithin or - Arnica extract - Cannabidiol - Colloidal silver - Panthenol and wherein a long-term treatment means is provided which is designed for lip treatment during a long-term care phase following the acute phase, comprising: - Retinal - Hyaluronic acid - Vitamin C - Microencapsulated high molecular weight hyaluronic acid - Bakuchiol - Ceramide NP - Squalane.

Description

The invention relates to a treatment agent for aftercare following lip injections. Lip augmentation is a surgical procedure in which the lips of individuals are injected with hyaluronic acid, particularly to give the lips greater volume. Such procedures are being performed in rapidly increasing numbers, particularly on women. One problem is that these procedures are often not performed professionally. In severe cases, further intervention is necessary, especially to reduce excessively injected lips, which appear like inflatable boats, to a normal size. Generally, a problem with lip augmentation using hyaluronic acid is that painful inflammation and swelling of the lips can occur after such a procedure. There is also a risk of nodules forming from the injected hyaluronic acid, which not only detracts from the overall appearance of the lips but can also lead to persistent pain. The invention is based on the objective of providing an efficient, health-promoting aftercare following lip injections with hyaluronic acid. The features of claim 1 are provided to solve this problem. Advantageous embodiments and expedient further developments of the invention are described in the dependent claims. The invention relates to treatment agents for aftercare following lip augmentation, wherein the treatment agents are designed for application to the lips of individuals. The treatment agents comprise a set for carrying out a multi-phase treatment with at least two treatment phases. An acute treatment agent is provided, which is designed for lip treatment during an acute phase immediately following lip augmentation. This agent comprises: - Arnica extract - Menthol - Lecithin or - Arnica extract - Cannabidiol - Colloidal silver - Panthenol. A long-term treatment product is available, designed for lip treatment during a long-term care phase following the acute phase. This product includes: - Retinal - Hyaluronic acid - Vitamin C - Microencapsulated high molecular weight hyaluronic acid - Bakuchiol - Ceramide NP - Squalane. The basic idea of ​​the invention is to carry out a multi-phase treatment of the lips of individuals after lip injection with hyaluronic acid using different treatment agents, in such a way that no undesirable complications such as inflammation or pain occur after the lip injection, regeneration of the lips is achieved after the procedures, and as a long-term effect, the maintenance and rejuvenation of the lip structure is achieved. The key here is that different treatment agents are applied in individual, successive phases, i.e., the treatment agents are applied one after the other for the after-treatment of lips within a predetermined time frame. According to the invention, at least two treatment agents are used for post-treatment in at least two successive phases. This involves using an acute treatment agent during an acute phase that immediately follows the lip augmentation and lasts 1 to 2 weeks. According to a first variant of the invention, the acute treatment agent contains: - Arnica extract - Menthol - Lecithin. Arnica extract (Arnica Montana Flower Extract) promotes the breakdown of bruises, reduces swelling, and has an anti-inflammatory effect. Menthol (Mentha Arvensis Leaf Oil) relieves pain and has a mild antibacterial effect. Lecithin improves the absorption and distribution of the active ingredients in the skin. According to a second embodiment of the invention, the acute treatment agent with arnica extract contains a substance that reduces swelling and bruising. In addition, arnica extract has anti-inflammatory properties and promotes blood circulation. The acute treatment also contains cannabidiol, a substance that relieves pain and inflammation and soothes sensitive lip skin. The acute treatment also contains colloidal silver, a substance that has an antibacterial effect and prevents infections. The acute treatment also contains panthenol vitamin B5, a substance that supports wound healing and has a moisturizing and soothing effect. According to the invention, a long-term treatment agent is further used during a long-term care phase, the duration of which is significantly longer than the duration of the acute phase and can in particular last for several weeks or even months. The long-term care phase advantageously follows directly after the acute phase. According to the first variant of the invention, the long-term treatment agent contains: - retinal - hyaluronic acid - vitamin C. Retinal (retinaldehyde) promotes cell regeneration, supports the even distribution of injected hyaluronic acid and prevents nodule formation in the lip. Hyaluronic acid (sodium hyaluronate), especially low molecular weight, provides moisture and stabilizes the hyaluronic acid injected into the lip. Vitamin C (Ascorbyl Palmitate) supports collagen formation and improves the stability and durability of hyaluronic acid. The acute treatment agent and the long-term treatment agent according to the first variant of the invention form a minimalist and effect-focused set for aftercare following lip injections. The ingredients of acute and long-term treatments can be produced cost-effectively while maintaining high efficacy. According to the second embodiment of the invention, the long-term treatment agent with microencapsulated high-molecular-weight hyaluronic acid contains a substance that provides long-lasting moisture to the treated lip and ensures the retention of hyaluronic acid in the lip. The encapsulation of the hyaluronic acid ensures a delayed release and thus prevents rapid degradation of hyaluronic acid in the lip. The long-term treatment product also contains bakuchiol, which can in principle be replaced by retinal, a substance that improves skin structure and stimulates collagen production without causing irritation in the lip. The long-term treatment product also contains Ceramide NP, a substance that strengthens the skin barrier of the lip, promotes moisture retention, and thus ensures a smooth, supple lip. The long-term treatment product also contains squalane, a substance that retains moisture and strengthens the lip skin without leaving a greasy residue. The aforementioned components of the acute treatment or long-term treatment are basic components that may be supplemented by further components, particularly depending on the number of phases of the multi-phase treatment and the corresponding training of the treatment products for the phases. According to both variants of the invention, the acute treatment agent and / or the long-term treatment agent can have a UV filter. The UV filter provides advantageous protection against UV rays with a sun protection factor of 30. The advantage of a UV filter is that it is a physical UV filter. In particular, the UV filter consists of zinc oxide and / or titanium dioxide. According to a beneficial advanced training, the long-term treatment contains the following additional components: - Algae extract: This binds moisture, has an antioxidant effect, and improves lip elasticity. - Peptide complex, especially Acetyl Tetrapeptide-5: This promotes an even distribution of hyaluronic acid in the treated lip. This substance also has an anti-inflammatory effect. - Shea butter: This provides long-lasting care and makes the lips soft and supple. In general, the long-term care phase of the treatment is designed to prolong the effects of the hyaluronic acid and keep the treated lip smooth and hydrated over the long term. The peptide complex and humectants such as hyaluronic acid and algae extract help maintain lip volume, while ceramides and squalane protect and repair the lip's skin barrier. According to an advantageous embodiment, the acute treatment agent comprises the following additional components: - Palmitoyl Tripeptide-38 - Papain and / or Bromelain - Low molecular weight hyaluronic acid. Palmitoyl Tripeptide-38 is used to ensure the even distribution of hyaluronic acid in the treated lip. Additionally, the acute treatment contains papain and / or bromelain, enzymes which not only reduce swelling and promote healing, but also prevent nodule formation in the treated lip by maintaining the elasticity of the lip tissue. This effect is enhanced and promoted by low-molecular-weight hyaluronic acid as a further component of the treatment. These additives allow for both an acute and a regeneration phase for the treated lip. According to a further advantageous embodiment, the treatment agents form a set with which a three-phase treatment is carried out. In addition to the acute treatment agent and the long-term treatment agent, the set includes a regenerative treatment agent comprising the following: - Palmitoyl Tripeptide-38 - Papain and / or Bromelain - Low molecular weight hyaluronic acid. The acute treatment and the long-term treatment are designed according to the two aforementioned variants. The regeneration treatment is the third treatment in the set. The regenerative treatment may also advantageously include Centella Asiatica and / or a UV filter. The regenerative treatment is used during a regeneration phase, which is advantageously followed by the long-term care phase. The regeneration phase, in turn, follows the acute phase. Furthermore, the acute phase advantageously covers a period of approximately one to two weeks. The regeneration phase is particularly advantageous at exactly 7 days. The treatment products used during the individual phases can be in the form of creams or balms. Each cream or balm can be stored in a container, allowing a person to take some of it with their finger and apply it to their lip. The treatment products are particularly advantageous when designed in the form of lipsticks. In particular, the lipsticks are designed in the form of twist-up sticks. This allows for more precise dosing when applying treatment products to the lip. The invention is explained below with reference to the drawings. They show: Fig. 1: First embodiment of the set according to the invention for aftercare of lips following lip augmentation. Fig. 2: Second embodiment of the set according to the invention for aftercare of lips following lip augmentation. Fig. 1 shows a first embodiment of a set 1 with treatment means for carrying out a multi-phase treatment of lips after lip injection with hyaluronic acid. Set 1 according to Fig. 1 has two lipsticks 2a, 2b which in this case have an identical structure, but this is not mandatory. Each lipstick 2a, 2b has a hollow cylindrical base 3 in which a stick 4 containing a treatment agent is stored. A rotating element 5 is attached to the underside of the base 3, and by rotating the stick 4, it can be extended slightly from the base 3 to apply the treatment agent to the lip. Each lipstick 2a, 2b has a sealing element (not shown). Set 1 according to Fig. 1 includes in lipstick 2a an acute treatment agent designed for lip treatment during an acute and regeneration phase immediately following lip injection. The acute treatment contains, in a minimal configuration according to a first variant: - Arnica extract - Menthol - Lecithin and according to a second variant: - Arnica extract - Cannabidiol - Colloidal silver - Panthenol. Lipstick 2b contains a long-term treatment agent designed for lip treatment during a long-term care phase following the acute and regeneration phase. The long-term treatment of the first variant includes: - Retinal - Hyaluronic acid - Vitamin C. The long-term treatment agent of the second variant includes: - microencapsulated high molecular weight hyaluronic acid - bakuchiol - ceramide NP - squalane. Both the acute treatment and the long-term treatment products advantageously contain an additional UV filter. Fig. 2 shows a second embodiment of the set 1 according to the invention. Set 1 according to Fig. 2 has three lipsticks 2a, 2b, 2c, which are again identically designed. The first lipstick 2a of set 1 according to Fig. 2 contains an acute treatment agent designed for use during an acute phase immediately following lip augmentation. The acute treatment agent corresponds to the acute treatment agent of the embodiment shown in Fig. 1. The second lipstick 2b of set 1 according to Fig. 2 contains a regenerative treatment agent designed for lip treatment during a regeneration phase following the acute phase, comprising: - Palmitoyl Tripeptide -38- Papain and / or Bromelain- Centella Asiatica (optional)- Low molecular weight hyaluronic acid- UV filter (optional). The third lipstick 2c of set 1 according to Fig. 2 contains a long-term treatment agent designed for lip treatment during a long-term care phase following the regeneration phase. The long-term treatment agent can be designed according to the embodiment shown in Fig. 1. Reference symbol list (1) Set (2a) Lipstick (2b) Lipstick (2c) Lipstick (3) Base (4) Stick (5) Twisting element

Claims

Treatment means for aftercare following lip augmentation, wherein the treatment means are designed for application to the lips of persons, characterized in that the treatment means are comprised of a set (1) for carrying out a multi-phase treatment with at least two treatment phases, wherein an acute treatment means is provided which is designed for lip treatment during an acute phase immediately following lip augmentation, comprising: - Arnica extract - Menthol - Lecithin or - Arnica extract - Cannabidiol - Colloidal silver - Panthenol and wherein a long-term treatment means is provided which is designed for lip treatment during a long-term care phase following the acute phase, comprising: - Retinal - Hyaluronic acid - Vitamin C - Microencapsulated high molecular weight hyaluronic acid - Bakuchiol - Ceramide NP - Squalane. Treatment agent according to one of claims 1, characterized in that the acute treatment agent and / or the long-term treatment agent comprises a UV filter as an additional component. Treatment agent according to claim 2, characterized in that the UV filter is a physical UV filter. Treatment agent according to claim 3, characterized in that the UV filter consists of zinc oxide and / or titanium dioxide. Treatment agent according to one of claims 1 to 4, characterized in that the long-term treatment agent comprises as additional components: - algae extract - peptide complex, in particular acetyl tetrapeptide-5 - shea butter. Treatment agent according to one of claims 1 to 5, characterized in that the acute treatment agent comprises as additional components: - Palmitoyl Tripeptide-38 - Papain and / or Bromelain - Low molecular weight hyaluronic acid. Treatment agent according to one of claims 1 to 5, characterized in that it forms a set (1) with which a three-phase treatment is carried out, wherein the set (1) comprises, in addition to the acute treatment agent and the long-term treatment agent, a regeneration treatment agent comprising: - Palmitoyl Tripeptide-38 - Papain and / or Bromelain - Low molecular weight hyaluronic acid. Treatment agent according to claim 7, characterized in that the regeneration treatment agent additionally comprises: - Centella Asiatica and / or - UV filter. Treatment agent according to claim 7, characterized in that the regeneration treatment agent is used during a regeneration phase, which is followed by the long-term care phase. Treatment means according to one of claims 1 to 9, characterized in that the acute phase comprises a period on the order of one to two weeks. Treatment device according to one of claims 1 to 10, characterized in that the long-term care phase extends over a significantly longer period than the acute phase. Treatment means according to claim 9, characterized in that the regeneration phase comprises a period on the order of one to two weeks. Treatment products according to any one of claims 1 to 12, characterized in that they are in the form of creams or balms. Treatment means according to one of claims 1 to 12, characterized in that they are in the form of lipsticks (2a, 2b, 2c). Treatment means according to claim 14, characterized in that the lipsticks (2a, 2b, 2c) are designed in the form of twist sticks.

Images